NL-OMON43101已完成不适用
A phase 1, two-part, randomized, open-label study to evaluate the relative bioavailability and food effect of test formulations of VX-152 and Ivacaftor in healthy subjects - Bioavailability and Food Effect Study of VX-152 and Ivacaftor
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male and female volunteers
- •18-55 yrs, inclusive
- •18.0-31.0 kg/m2, inclusive
- •non-smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. The volunteers does not have a history of hemolysis and the blood analyses at screening are not indicative of G6PD deficiency or chronic hemolysis. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 56 days from the start of the study. In case of donating more than 0.5 liters of blood in the 56 days prior the start of this study.
研究者
相似试验
进行中（未招募）
1 期
A study to compare two different formulations of fenebrutinib and to assess the effect of food and rabeprazole on the processing of fenebrutinib by the body in healthy participantsISRCTN23183841F. Hoffmann-La Roche Ltd84
进行中（未招募）
1 期
Pharmacokinetics, safety, and tolerability of a single-dose of SAR443765 in healthy Japanese participantsJPRN-jRCT2071220112Tanaka Tomoyuki12
进行中（未招募）
1 期
A Phase 1, open label study to evaluate the pharmacokinetics, safety and tolerability of single subcutaneous dose amlitelimab in healthy adult participants.JPRN-jRCT2071220049Tanaka Tomoyuki24
已完成
Unknown
A parallel, Phase 1, randomized, open label study to evaluate the pharmacokinetics, safety and tolerability of single subcutaneous dose amlitelimab in healthy Chinese and Japanese adult participants.KCT0008635Sanofi-Aventis Korea24
进行中（未招募）
1 期
Single-dose study of SAR441344 in healthy Chinese and Japanese participantsJPRN-jRCT2071220098Tanaka Tomoyuki36